BCEIE › News › BLUEJET

Results

Blue Jet Healthcare: The financial results for the period ended September 30, 2026

Blue Jet Healthcare (BLUEJET) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹11,214 crore.

BCEIE News Desk · Published 5 Nov 2026, 01:09 pm IST · Filing received 5 Nov 2026, 12:53 pm IST

What happened

Blue Jet Healthcare (BLUEJET) filed a disclosure with the exchanges on 5 November 2026 at 12:53 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Blue Jet Healthcare is a small-cap company in the Healthcare sector, with a market value of about ₹11,214 crore.

The stock last traded at ₹592.5, against a 52-week range of ₹325–₹647.8 (8.5% below the high).

Before this filing the shares had moved −8.4% over the month and −16.0% over three months. Average daily turnover over the last 20 sessions was about ₹13.43 crore.

Promoters held 73.15% at the end of Q2 FY27, down 6.66% points from the previous quarter. Foreign institutions owned 0.62% and domestic institutions 9.12%.

Quarterly results (standalone, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2635591.25.26
Q2 FY2616552.13.01
Q3 FY2619240.22.32
Q4 FY2623564.33.71
Q1 FY2729378.34.51

What history shows

BCEIE's records show 2 previous results filings from the company since May 2026.

Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.0% over five days; 57% of them rose the next day.

Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.
  • 5 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.